SEXUAL TIPPING POINT MODEL CITATIONS IN THE PROFESSIONAL LITERATURE:

Pfaus, J. G., Jones, S. L., Flanagan-Cato, L. M., & Blaustein, J. D. (2015). Female Sexual Behavior. In Knobil and Neill's Physiology of Reproduction (pp. 2287–2370). Elsevier. http://doi.org/10.1016/B978-0-12-397175-3.00050-8

Perelman, M. A. Invited Commentary: Sex Coaching for Non-Sexologist Physicians: How to Use the Sexual Tipping Point Model. The Journal of Sexual Medicine, Vol.15, Issue 12. Dec. 2018.

Bossio, Jennifer & Basson, Rosemary & Driscoll, Miriam & Correia, Shauna & Brotto, Lori. (2018). Mindfulness-Based Group Therapy for Men With Situational Erectile Dysfunction: A Mixed-Methods Feasibility Analysis and Pilot Study. The Journal of Sexual Medicine. 15. 1478-1490. 10.1016/j.jsxm.2018.08.013.

Abdel-Hamid, I. A., & Ali, O. I. (2018). Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment. The world journal of men's health, 36(1), 22-40.

Rullo, J., Faubion, S. S., Hartzell, R., Goldstein, S., Cohen, D., Frohmader, K., ... & Goldstein, I. (2018). Biopsychosocial Management of Female Sexual Dysfunction: A Pilot Study of Patient Perceptions From 2 Multi-Disciplinary Clinics. Sexual medicine.

Rogers, R. G., Pauls, R. N., Thakar, R., Morin, M., Kuhn, A., Petri, E., ... & Lee, J. (2018). An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction. Neurourology and urodynamics, 37(4), 1220-1240.

Perelman, M. A. (2018). Why the Sexual Tipping Point® Is a “Variable Switch Model.” Current Sexual Health Reports, 6(2), 1–6. http://doi.org/10.1007/s11930-018-0148-3 Pfaus, J. G., & Jones, S. L. (2018). Central Nervous System Anatomy and Neurochemistry of Sexual Desire. Textbook of Female Sexual Function and Dysfunction: Diagnosis and Treatment, 25-51.

Tuiten, A., van Rooij, K., Bloemers, J., Eisenegger, C., van Honk, J., Kessels, R., ... & Koppeschaar, H. P. F. (2018). 167 Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials. The Journal of Sexual Medicine, 15(7), S199-S200.

Tuiten, A., van Rooij, K., Bloemers, J., Eisenegger, C., van Honk, J., Kessels, R., ... & Koppeschaar, H. P. (2018). Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials. The journal of sexual medicine, 15(2), 201-216.

Ahmed, A. F., Alshahrani, S., Morgan, A., Gabr, A. H., Abdel-Razik, M., & Daoud, A. (2017). Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men. Arab journal of urology, 15(4), 366-371.

Avery-Clark, C., & Weiner, L. (2017). Behavioral Approach to Sex Therapy. The Wiley Handbook of Sex Therapy, 165.

Butcher, M. J., & Serefoglu, E. C. (2017). Treatment of Delayed Ejaculation. In The Textbook of Clinical Sexual Medicine (pp. 255-269). Springer, Cham.

Ferenidou, F., Kirana, P. S., & Athanasiadis, L. (2017). Women's sexual function through sexual response models: From DSM-IV to DSM-5. Psychiatrike= Psychiatriki, 28(4), 322-331.

Levine, S. B. (2017). Why sex is important: background for helping patients with their sexual lives. BJPsych Advances, 23(5), 300-306.

Perelman, M. A. (2017a). Delayed Ejaculation in Couple and Family Therapy. In J. Lebow, A. Chambers, & D. C. Breunlin (Eds.), Encyclopedia of Couple and Family Therapy (Vol. 15, pp. 1–6). Cham: Springer International Publishing. http://doi.org/10.1007/978-3-319-15877-8_456-1

Perelman, M. A. (2017b). Sexual Tipping Point Model in Couple and Family Therapy. In J. Lebow, A. Chambers, & D. C. Breunlin (Eds.), Encyclopedia of Couple and Family Therapy (Vol. 2, pp. 1–11). Cham: Springer International Publishing. http://doi.org/10.1007/978-3-319-15877-8_709-1

Langer, R., Langer, B., Mahajan, R., Sharma, E., Gupta, R. K., & Kumari, R. (2017). Exploring psychosocial issues in patients of erectile dysfunction: a study in tertiary care setting. International Journal of Medical Science and Public Health, 6(6), 1050-1056.

Levin, R. J. (2017). The human sexual response cycle. In W. W. Ishak (Ed.), Textbook of clinical sexual medicine (pp. 39–51). Cham, Switzerland: Springer.

Althof, S., Meston, C., Perelman, M., Handy, A., Kilimnik, C., & Stanton, A. (2017). Opinion Paper: On the Diagnosis/Classification of Sexual Arousal Concerns in Women. J Sex Med, 1–7. http://doi.org/10.1016/j.jsxm.2017.08.013

Perelman, M. A. (2016). Psychosexual therapy for delayed ejaculation based on the Sexual Tipping Point model. Translational Andrology and Urology, 5(4), 563–575. http://doi.org/10.21037/tau.2016.07.05

Levine S.B. (2016) Why Is Sex Important?. In: Lipshultz L., Pastuszak A., Goldstein A., Giraldi A., Perelman M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY

Perelman, M. A. (2016a). Introduction: Advocating for a Transdisciplinary Approach to the Management of Sexual Disorders. In L. I. Lipshultz, A. W. Pastuszak, A. Giraldi, A. T. Goldstein, & M. A. Perelman (Eds.), Management of Sexual Dysfunction in Men and Women (pp. 1–8). New York, NY: Springer New York. http://doi.org/10.1007/978-1-4939-3100-2_1

Perelman, M. A. (2016). Introduction: Advocating For Transdisciplinary Treatment Of Sexual Dysfunction Employing A Biopsychosocial-Behavioral & Cultural Approach. In Management Of Sexual Dysfunction In Men And Women: An Integrated Approach. Eds: Lipshultz L, Pastuaszak A, Giraldi A, Goldstein A, Perelman MA, Springer, New York.

Perelman, M. A. (2016b). Reexamining the Definitions of PE and DE. Journal of Sex and Marital Therapy, 43(7), 633–644. http://doi.org/10.1080/0092623X.2016.1230161

Perelman, M. A. (2016c). Why the Sexual Tipping Point® Model? Current Sexual Health Reports, 8(1), 39–46. http://doi.org/10.1007/s11930-016-0066-1

Perelman, M. A., & Watter, D. N. (2016). Psychological Aspects of Erectile Dysfunction. In Contemporary Treatment of Erectile Dysfunction (pp. 29–43). Springer International Publishing. http://doi.org/10.1007/978-3-319-31587-4_3

Parish, S. J., & Hahn, S. R. (2016). The Epidemiology and Diagnosis of Hypoactive Sexual Desire Disorder and Causes of HSDD: Situational, Depression, Drugs, Chronic Illnesses, and Hormonal Depletion. In Management of Sexual Dysfunction in Men and Women (pp. 223-232). Springer, New York, NY.

Krapf, J. M., Buster, J. E., & Goldstein, A. T. (2016). Management of Hypoactive Sexual Desire Disorder (HSDD). In Management of Sexual Dysfunction in Men and Women(pp. 233-249). Springer, New York, NY.

Levine S.B. (2016) Why Is Sex Important?. In: Lipshultz L., Pastuszak A., Goldstein A., Giraldi A., Perelman M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY

Clayton, A. H., Alkis, A. R., Parikh, N. B., & Votta, J. G. (2016). Sexual dysfunction due to psychotropic medications. Psychiatric Clinics, 39(3), 427-463.

Reed, G. M., Drescher, J., Krueger, R. B., Atalla, E., Cochran, S. D., First, M. B., ... & Briken, P. (2016). Disorders related to sexuality and gender identity in the ICD‐11: revising the ICD‐10 classification based on current scientific evidence, best clinical practices, and human rights considerations. World Psychiatry, 15(3), 205-221.

Parish, S. J., Goldstein, A. T., Goldstein, S. W., Goldstein, I., Pfaus, J., Clayton, A. H., ... & Komisaruk, B. (2016). Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions—part II. The journal of sexual medicine, 13(12), 1888-1906.

Perelman, M. A. (2015). Advocating For a Transdisciplinary Perspective in Sexual Medicine. Current Sexual Health Reports, 7(1), 1–2. http://doi.org/10.1007/s11930-015-0040-3

Brotto, L. A., Graham, C. A., Paterson, L. Q., Yule, M. A., & Zucker, K. J. (2015). Women's Endorsement of Different Models of Sexual Functioning Supports Polythetic Criteria of Female Sexual Interest/Arousal Disorder in DSM‐5. The journal of sexual medicine, 12(9), 1978-1981.

Belkin, Z. R., Krapf, J. M., & Goldstein, A. T. (2015). Drugs in early clinical development for the treatment of female sexual dysfunction. Expert opinion on investigational drugs, 24(2), 159-167.

Boswell, E. N., & Dizon, D. S. (2015). Breast cancer and sexual function. Translational andrology and urology, 4(2), 160.

Pfaus, J. G., Jones, S. L., Flanagan-Cato, L., & Blaustein, J. D. (2015). Chapter 50: Female sexual behavior. In A. M. Plant & A. J. Zeleznik (Eds.), Knobil & Neill’s Physiology of reproduc-tion, fourth edition (pp. 22872370). New York: Elsevier.

Giraldi, A., Kristensen, E., & Sand, M. (2015). Endorsement of models describing sexual response of men and women with a sexual partner: an online survey in a population sample of Danish adults ages 20–65 years. The journal of sexual medicine, 12(1), 116-128.

Perelman, M. A. (2014). The History of Sexual Medicine. In APA Handbook of Sexuality and Psychology, Vol. 2: Contextual Approaches (pp. 137–179). Washington: American Psychological Association. http://doi.org/10.1037/14194-005

Clayton, A. H., El Haddad, S., Iluonakhamhe, J. P., Ponce Martinez, C., & Schuck, A. E. (2014). Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert opinion on drug safety, 13(10), 1361-1374.

Levin, R. J. (2014). The pharmacology of the human female orgasm—its biological and physiological backgrounds. Pharmacology Biochemistry and Behavior, 121, 62-70.

Strassberg, D. S., Perelman, M. A., & Watter, D. N. (2014). Sexual Dysfunction in Males. In L. Grossman & S. Walfish (Eds.), Translating Psychological Research into Practice. New York.

Pastuszak, A. W. (2014). Current diagnosis and management of erectile dysfunction. Current sexual health reports, 6(3), 164-176.

Dizon, D. S., Suzin, D., & McIlvenna, S. (2014). Sexual health as a survivorship issue for female cancer survivors. The oncologist, theoncologist-2013.

Perelman, M. A., & Grill, E. A. (2013). The role of sex therapy for male infertility. In P. N. Schlegel & M. Goldstein (Eds.), Surgical and Medical Management of Male Infertility (pp. 204–218). Cambridge: Cambridge University Press.

Kingsberg, S. A., & Rezaee, R. L. (2013). Hypoactive sexual desire in women. Menopause, 20(12), 1284-1300.

Corona, G., Ricca, V., Bandini, E., Rastrelli, G., Casale, H., Jannini, E. A., ... & Maggi, M. (2012). SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. The journal of sexual medicine, 9(8), 2017-2026.

Althof, S. E., Perelman, M. A., & Rosen, R. C. (2011). The Subjective Sexual Arousal Scale for Men (SSASM): Preliminary Development and Psychometric Validation of a Multidimensional Measure of Subejctive Male Sexual Arousal. Journal of Sexual Medicine, 8, 2255–2268.

Allers, K. A., & Sommer, B. (2011). Paradigms for Preclinical Investigations of Female Sexual Function and Dysfunction (HSDD and FSAD). In Sexual Dysfunctions-Special Issues. InTech.

S Calabro, R., Polimeni, G., Ciurleo, R., Casella, C., & Bramanti, P. (2011). Neurogenic ejaculatory disorders: focus on current and future treatments. Recent patents on CNS drug discovery, 6(3), 205-221.

Hayes, R. D. (2011). Circular and linear modeling of female sexual desire and arousal. Journal of Sex Research, 48(2-3), 130-141.

Jannini, E. A., McMahon, C., Chen, J., Aversa, A., & Perelman, M. A. (2011). The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation. Journal of Sexual Medicine, 8(8), 2135–2143. http://doi.org/10.1111/j.1743-6109.2011.02401.x

Perelman, M. A. (2011a). Commentary on the DSM-V Considerations Regarding Premature Ejaculation. Journal of Sex and Marital Therapy, 37(2), 145–150.

Perelman, M. A. (2011b). Erectile Dysfunction and Depression: Screening and Treatment. The Urologic Clinics of North America, 38(2), 125–139. http://doi.org/10.1016/j.ucl.2011.03.004

Perelman, M. A. (2011c). The Sexual Tipping Point: A Mind/Body Model for the Past, Present and Future. Presented at the 20th World Congress for Sexual Health, Glasgow, UK.

Potter, J. (2011). Sexuality and intimacy after cancer. Excellent Care for Cancer Survivors: A Guide to Fully Meet Their Needs in Medical Offices and in the Community: A Guide to Fully Meet Their Needs in Medical Offices and in the Community, 175.

Clayton, A. H., & Hamilton, D. V. (2010). Female sexual dysfunction. Psychiatric Clinics, 33(2), 323-338.

K, W., Ralph, D., Levin, R. J., Corona, G., & Perelman, M. A. (2010). Comments on “Considerations for a Better Definition of Male Orgasmic Disorder in DSM V.” Journal of Sexual Medicine, 7(2pt1), 690–695. http://doi.org/10.1111/j.1743-6109.2009.01683.x

Krychman, M., Kellogg-Spadt, S., & Clayton, A. (2010). Sexual Health Fundamentals For Patient Care: A Report On 2010 Consensus Outcomes And Guidance For Women's Health Professionals: 061. The Journal of Sexual Medicine, 7, 171.

Segraves, R. T. (2010). Considerations for a better definition of male orgasmic disorder in DSM V. The journal of sexual medicine, 7(2), 690-695.

Althof, S. (2010). Sex therapy: Advances in paradigms, nomenclature, and treatment. Academic Psychiatry, 34(5), 390-396.

Guay, A., & Traish, A. (2010). Testosterone therapy in women with androgen deficiency: Its time has come. Curr Opin Investig Drugs, 11, 1116-1126.

Burnett, A. L., Goldstein, I., Andersson, K. E., Argiolas, A., Christ, G., Park, K., & Xin, Z. C. (2010). Future sexual medicine physiological treatment targets. The journal of sexual medicine, 7(10), 3269-3304.

Perelman, M. A. (2009a). Integrated sex therapy: a psychosocial-cultural perspective integrating behavioral, cognitive, and medical approaches. In C. C. Carson, R. S. Kirby, & M. G. Wyllie (Eds.), Textbook of Erectile Dysfunction (2nd ed., pp. 298–305). London: Informa Healthcare.

Perelman, M. A. (2009b). The sexual tipping point: a mind/body model for sexual medicine. Journal of Sexual Medicine, 6(3), 227–632. http://doi.org/10.1111/j.1743-6109.2008.01177.x

Wylie, K., & Mimoun, S. (2009). Sexual response models in women. Maturitas, 63(2), 112-115.

Kingsberg, S. A., & Janata, J. W. (2007). Female sexual disorders: assessment, diagnosis, and treatment. Urologic Clinics of North America, 34(4), 497-506.

Perelman, M. A. (2007a). Clinical application of CNS-acting agents in FSD. Journal of Sexual Medicine, 4 Suppl 4(s4), 280–290. http://doi.org/10.1111/j.1743-6109.2007.00611.x

Perelman, M. A. (2007b). The impact of relationship variables on the etiology, diagnosis and treatment of erectile dysfunction. Advances in Primary Care Medicine: Clinical Update, 3, 3–6.

Traish, A., Guay, A. T., Spark, R. F., & Testosterone Therapy in Women Study Group. (2007). COMMENTARY: Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women Misguided? A Commentary. The journal of sexual medicine, 4(5), 1223-1235.

Diamond, L. E., Diamond, L. E., Earle, D. C., Earle, D. C., Heiman, J. R., Rosen, R. C., et al. (2006). An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. J Sex Med, 3(4), 628–638. http://doi.org/10.1111/j.1743-6109.2006.00268.x

 Rowland, D. L., & Perelman, M. A. (2006). Retarded ejaculation. World Journal of Urology, 24(6), 645–652.